INTUITIVE SURGICAL INC
ISRG
74 insider filings · Latest: Oct 10, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| May 11, 2026 | May 11 11:11 PM | Gary LoebEVP & Chief Legal and Complian | Sale | 400 | $446.95 | $178.8K | 6,120(D) | View → |
| May 11, 2026 | May 11 8:35 PM | GARY LOEB | Proposed Sale | 400 | $450.06 | $180.0K | — | View → |
| Apr 29, 2026 | Apr 29 9:38 PM | Amy L LaddDirector | Sale | 119 | $463.50 | $55.2K | 120(D) | View → |
| Apr 28, 2026 | Apr 29 9:38 PM | Amy L LaddDirector | Sale | 500 | $473.46 | $236.7K | 239(D) | View → |
| Apr 28, 2026 | Apr 28 8:31 PM | AMY LADD | Proposed Sale | 619 | $470.99 | $291.5K | — | View → |
| Apr 27, 2026 | Apr 27 8:37 PM | MCADAMS FAMILY REVOCABLE LIVING TR U/A DTD 01/28/2009 | Proposed Sale | 30,417 | $470.91 | $14.3M | — | View → |
| Mar 10, 2026 | Mar 11 5:46 PM | Curet MyriamEVP & Chief Medical Officer | Sale | 105 | $493.95 | $51.9K | 0(D) | View → |
| Mar 10, 2026 | Mar 10 8:47 PM | MYRIAM CURET MCADAMS | Proposed Sale | 105 | $493.95 | $51.9K | — | View → |
| Mar 9, 2026 | Mar 10 6:24 PM | Mark BrosiusSVP & Chief Mfg and Supply Cha | Sale | 645 | $485.01 | $312.8K | 1,613(D) | View → |
| Mar 6, 2026 | Mar 10 6:24 PM | Mark BrosiusSVP & Chief Mfg and Supply Cha | Sale | 648 | $490.19 | $317.6K | 2,258(D) | View → |
| Mar 5, 2026 | Mar 5 11:38 PM | Mark BrosiusSVP & Chief Mfg and Supply Cha | Sale | 648 | $495.20 | $320.9K | 2,906(D) | View → |
| Mar 4, 2026 | Mar 5 11:38 PM | Mark BrosiusSVP & Chief Mfg and Supply Cha | Sale | 2,362 | $498.68 | $1.2M | 3,554(D) | View → |
| Mar 3, 2026 | Mar 5 11:38 PM | Mark BrosiusSVP & Chief Mfg and Supply Cha | Sale | 648 | $488.10 | $316.3K | 5,916(D) | View → |
| Mar 5, 2026 | Mar 5 9:43 PM | MARK BROSIUS | Proposed Sale | 1,714 | $501.18 | $859.0K | — | View → |
| Mar 4, 2026 | Mar 4 9:43 PM | BRIAN MILLER | Proposed Sale | 8,368 | $497.42 | $4.2M | — | View → |
| Mar 3, 2026 | Mar 3 11:17 PM | Fredrik WidmanVP Corporate Controller | Sale | 118 | $487.18 | $57.5K | 1,026(D) | View → |
| Feb 27, 2026 | Mar 3 11:17 PM | Fredrik WidmanVP Corporate Controller | Sale | 249 | $499.71 | $124.4K | 909(D) | View → |
| Mar 3, 2026 | Mar 3 10:34 PM | Curet MyriamEVP & Chief Medical Officer | Sale | 4,728 | $487.18 | $2.3M | 409(I) | View → |
| Mar 2, 2026 | Mar 3 10:34 PM | Curet MyriamEVP & Chief Medical Officer | Sale | 125 | $492.59 | $61.6K | 5,137(I) | View → |
| Mar 3, 2026 | Mar 3 9:32 PM | MARK BROSIUS | Proposed Sale | 3,327 | $496.25 | $1.7M | — | View → |
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Feb 26, 2026 | Feb 27 7:53 PM | Henry L CharltonEVP & Chief Commercial and Mkt | Grant/Award | 7,623 | $0.00 | 4,032(D) | View → |
| Feb 26, 2026 | Feb 27 7:45 PM | Jamie SamathEVP & CFO & Enterprise Technol | Option Exercise | 3,396 | $0.00 | 4,463(D) | View → |
| Feb 26, 2026 | Feb 27 7:45 PM | Jamie SamathEVP & CFO & Enterprise Technol | Grant/Award | 10,311 | $0.00 | 6,720(D) | View → |
| Feb 26, 2026 | Feb 27 7:36 PM | Gary LoebEVP & Chief Legal and Complian | Grant/Award | 4,634 | $0.00 | 3,584(D) | View → |
| Feb 26, 2026 | Feb 27 7:36 PM | Gary LoebEVP & Chief Legal and Complian | Option Exercise | 2,442 | $0.00 | 2,746(D) | View → |
| Feb 26, 2026 | Feb 27 7:00 PM | Curet MyriamEVP & Chief Medical Officer | Grant/Award | 2,793 | $0.00 | 8,378(D) | View → |
| Feb 26, 2026 | Feb 27 7:00 PM | Curet MyriamEVP & Chief Medical Officer | Option Exercise | 4,654 | $0.00 | 0(D) | View → |
| Feb 26, 2026 | Feb 27 6:52 PM | Fredrik WidmanVP Corporate Controller | Grant/Award | 1,627 | $0.00 | 1,627(D) | View → |
| Feb 26, 2026 | Feb 27 6:52 PM | Fredrik WidmanVP Corporate Controller | Option Exercise | 989 | $0.00 | 1,133(D) | View → |
| Feb 26, 2026 | Feb 27 6:42 PM | David J. RosaDirector, Chief Executive Officer (CEO) | Grant/Award | 21,247 | $0.00 | 13,441(D) | View → |
| Feb 26, 2026 | Feb 27 6:42 PM | David J. RosaDirector, Chief Executive Officer (CEO) | Option Exercise | 6,105 | $0.00 | 6,866(D) | View → |
| Feb 26, 2026 | Feb 27 6:32 PM | Gary S GuthartDirector | Grant/Award | 8,778 | $0.00 | 26,334(D) | View → |
| Feb 26, 2026 | Feb 27 6:32 PM | Gary S GuthartDirector | Option Exercise | 8,393 | $0.00 | 10,299(D) | View → |
| Feb 26, 2026 | Feb 27 6:19 PM | Mark BrosiusSVP & Chief Mfg and Supply Cha | Grant/Award | 7,721 | $0.00 | 4,928(D) | View → |
| Feb 26, 2026 | Feb 27 6:19 PM | Mark BrosiusSVP & Chief Mfg and Supply Cha | Option Exercise | 2,595 | $0.00 | 2,918(D) | View → |
| Feb 10, 2026 | Feb 11 10:37 PM | Curet MyriamEVP & Chief Medical Officer | Option Exercise | 943 | $229.39 | 838(D) | View → |
| Feb 10, 2026 | Feb 11 10:17 PM | Fredrik WidmanVP Corporate Controller | Option Exercise | 567 | $0.00 | 567(D) | View → |
| Feb 10, 2026 | Feb 10 9:28 PM | David J. RosaDirector, Chief Executive Officer (CEO) | Option Exercise | 1,436 | $0.00 | 1,436(D) | View → |
| Feb 10, 2026 | Feb 10 9:18 PM | Gary S GuthartDirector | Option Exercise | 2,633 | $0.00 | 2,633(D) | View → |
| Feb 10, 2026 | Feb 10 8:51 PM | Gary LoebEVP & Chief Legal and Complian | Option Exercise | 315 | $0.00 | 314(D) | View → |